Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indications
10 nov. 2023 07h30 HE
|
Pacira BioSciences
— EXPAREL is the only FDA-approved single-dose regional analgesic to safely demonstrate four days of superiority versus bupivacaine in two clinical studies — — New indications for use as an...
Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in November
07 nov. 2023 08h00 HE
|
Pacira BioSciences
TAMPA, Fla., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the following two healthcare...
Pacira BioSciences Reports Third Quarter 2023 Financial Results
02 nov. 2023 08h00 HE
|
Pacira BioSciences
-- New ASA initiatives to advance education and innovation for the anesthesia community -- -- PDUFA action date for EXPAREL as a lower extremity nerve block on track for November 13, 2023 -- --...
Pacira to Report Third Quarter 2023 Financial Results on Thursday November 2, 2023
26 oct. 2023 08h00 HE
|
Pacira BioSciences
TAMPA, Fla., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its third quarter financial results before the open of the U.S. markets on...
American Society of Anesthesiologists Announces New Industry Supporter Pacira BioSciences, Inc.
12 oct. 2023 08h00 HE
|
Pacira BioSciences
SCHAUMBERG, Ill. and TAMPA, Fla., Oct. 12, 2023 (GLOBE NEWSWIRE) -- The American Society of Anesthesiologists (ASA) today announced Pacira BioSciences, Inc. (Nasdaq: PCRX) has joined ASA’s Industry...
Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors
10 oct. 2023 08h00 HE
|
Pacira BioSciences
-- Enhances diversity and expertise in key areas including scientific, commercial, and financial -- TAMPA, Fla., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the...
American Society of Anesthesiologists and Pacira BioSciences, Inc. Announce New Grant to Advance Education and Enhance Patient Care
02 oct. 2023 08h00 HE
|
Pacira BioSciences
SCHAUMBURG, Ill. and TAMPA, Fla., Oct. 02, 2023 (GLOBE NEWSWIRE) -- The American Society of Anesthesiologists (ASA) and Pacira BioSciences, Inc. (Nasdaq: PCRX), today announced a new grant of $2.5...
Pacira BioSciences Announces Leadership Succession Plan
26 sept. 2023 16h30 HE
|
Pacira BioSciences
David Stack to Retire as Chairman and CEO Once Successor is Appointed Board Has Initiated Search for Successor TAMPA, Fla., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq:...
Pacira BioSciences Announces Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference
06 sept. 2023 08h00 HE
|
Pacira BioSciences
TAMPA, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced its participation in an analyst-led fireside chat at the H.C. Wainwright 25th Annual Global...
Pacira BioSciences Reports Second Quarter 2023 Financial Results
02 août 2023 08h00 HE
|
Pacira BioSciences
-- Conference call today at 8:30 a.m. ET -- TAMPA, Fla., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain...